Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

SELL
$14.16 - $24.02 $2,902 - $4,924
-205 Reduced 22.65%
700 $10,000
Q4 2021

Jan 20, 2022

SELL
$26.0 - $37.03 $44,200 - $62,951
-1,700 Reduced 65.26%
905 $28,000
Q3 2021

Nov 01, 2021

BUY
$29.75 - $37.99 $6,217 - $7,939
209 Added 8.72%
2,605 $87,000
Q2 2021

Aug 02, 2021

BUY
$27.5 - $38.19 $65,890 - $91,503
2,396 New
2,396 $88,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $583M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track High Mark Wealth Management LLC Portfolio

Follow High Mark Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Mark Wealth Management LLC with notifications on news.